BRIEF published on 04/03/2026 at 07:05, 4 months 1 day ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 4 months 1 day ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
PRESS RELEASE published on 04/03/2026 at 07:00, 4 months 1 day ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
BRIEF published on 12/11/2025 at 07:05, 7 months 24 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
BRIEF published on 12/11/2025 at 07:05, 7 months 24 days ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
PRESS RELEASE published on 12/11/2025 at 07:00, 7 months 24 days ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 8 months 6 days ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
BRIEF published on 11/17/2025 at 07:05, 8 months 17 days ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
PRESS RELEASE published on 11/17/2025 at 07:00, 8 months 17 days ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
BRIEF published on 10/14/2025 at 07:05, 9 months 21 days ago Innate Pharma Highlights Lacutamab at Analyst and Investor Event Investors Clinical Trial Innate Pharma Lacutamab Sézary Syndrome
Published on 08/05/2026 at 02:10, 1 hour 46 minutes ago Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance
Published on 08/04/2026 at 22:30, 5 hours 26 minutes ago Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 16:25, 11 hours 31 minutes ago ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 12 hours 56 minutes ago Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Published on 08/04/2026 at 22:03, 5 hours 52 minutes ago #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 5 hours 54 minutes ago EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 7 hours 50 minutes ago Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:39, 8 hours 16 minutes ago EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again
Published on 08/04/2026 at 18:32, 9 hours 23 minutes ago Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 10 hours 11 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/04/2026 at 16:00, 11 hours 56 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 08/04/2026 at 08:15, 19 hours 41 minutes ago Covivio - Conditions of availability of the 2026 Half-year report
